Summary of critical QQ1 2024 metrics (USD, unless noted):
- Revenue: 0 (null in provided data)
- Gross profit / gross margin: not applicable (no revenue)
- Research and Development (R&D) expenses: $1,901,000
- General and Administrative (G&A) expenses: $1,667,000
- Selling and Marketing expenses: not disclosed
- Operating expenses (R&D + G&A): $3,568,000
- EBITDA: -$771,000
- Operating income: -$3,568,000
- Other income/expenses, net: $2,630,753
- Income before tax: -$937,000
- Income tax expense: -$132,000
- Net income: -$805,000
- Earnings per share (basic and diluted): -$0.0034
- Weighted average shares outstanding: 234,012,000
- Net cash from operating activities: -$4,433,000
- Free cash flow: -$4,433,000
- Cash and cash equivalents at period end: $8,165,000
- Short-term investments: $18,827,499
- Total assets / liabilities: balance sheet data shows liquidity emphasis with negative items in some fields indicating data irregularities; total liabilities reported as -$34,239,631 and total stockholders’ equity as $34,239,631 in the provided dataset.
- Key liquidity ratios (from ratiosInfo): current ratio 3.30, quick ratio 3.30, cash ratio 3.17
- DSO / DPO / CCC: days payable outstanding reported as 720.16 days; cash conversion cycle noted as -720.16 days (indicative of non-cash working capital dynamics in the data)
- Profitability benchmarks: all margin metrics (gross, operating, pretax, net) are effectively non-applicable or negative given the lack of revenue.
- Valuation/market metrics (from ratiosInfo): price-to-earnings negative (as expected for a net loss), price-to-book 72.25, enterprise value multiple negative; price-to-free-cash-flow negative.
- Additional context: the dataset contains an “earningsTranscript” field with no entries and no peer comparables listed for NEUP.